CuRatio is a provider of cancer management services that utilizes Deep Learning-powered pathology analysis to deliver precise diagnoses and prognoses for cancer patients. The platform enables personalized treatment plans tailored to the unique characteristics of each patient's cancer, improving treatment efficacy and patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer diagnoses and prognoses rely on pathology analysis, which can be subjective and may not always capture the unique characteristics of each patient's cancer. This can lead to less effective, generalized treatment plans.
Solution
The company aims to provide cancer management services using deep learning-powered pathology analysis to deliver precise diagnoses and prognoses for cancer patients. The platform intends to enable personalized treatment plans tailored to the unique characteristics of each patient's cancer, potentially improving treatment efficacy and patient outcomes.
Target Audience
The primary customers are cancer patients and healthcare providers involved in cancer management.
Features
- Deep learning-powered pathology analysis
- Precise diagnoses and prognoses
- Personalized treatment plans